enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: NVNO) | Delayed: 6.87 +0.14 (2.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.73 | 52 Week High | $ | |||
| Open | $6.78 | 52 Week Low | $ | |||
| Day High | $7.45 | P/E | N/A | |||
| Day Low | $6.78 | EPS | $ | |||
| Volume | 57,415 | |||||
